Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$34.4M |
| 2 |
LM
Legg Mason, Inc.
LM
|
+$15.7M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$12.8M |
| 4 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$12M |
| 5 |
GLIBA
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
|
+$8.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$44.5M |
| 2 |
CZR
Caesars Entertainment Corporation
CZR
|
+$28.2M |
| 3 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
+$27M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$21M |
| 5 |
IBKC
IBERIABANK Corp
IBKC
|
+$19.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 16.96% |
| 3 | Financials | 14.62% |
| 4 | Consumer Discretionary | 8.11% |
| 5 | Industrials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
ANI Pharmaceuticals
ANIP
$1.73B
| $670K | 0.06% |
16,439
+9,661
| +143% | +$514K |
|
377
Digital Realty Trust
DLR
$70.5B
| $666K | 0.06% |
+4,791
| New | +$609K |
|
|
WDR
378
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $666K | 0.06% |
58,483
-93,424
| -62% | -$1.39M |
|
|
GOOS
379
Canada Goose Holdings
GOOS
$854M
| $665K | 0.06% |
+33,453
| New | +$936K |
|
380
IDEX
IEX
$17.3B
| $661K | 0.06% |
+4,787
| New | +$751K |
|
381
SunCoke Energy
SXC
$822M
| $661K | 0.06% |
171,701
-43,070
| -20% | -$218K |
|
382
Pebblebrook Hotel Trust
PEB
$2.09B
| $658K | 0.06% |
60,427
-2,722
| -4% | -$55.4K |
|
383
New York Times
NYT
$10.6B
| $656K | 0.06% |
21,357
-51,543
| -71% | -$1.77M |
|
384
Ubiquiti
UI
$33.8B
| $656K | 0.06% |
4,631
+977
| +27% | +$149K |
|
385
Alphabet (Google) Class A
GOOGL
$4.22T
| $653K | 0.06% |
11,240
+2,480
| +28% | +$168K |
|
386
Kaiser Aluminum
KALU
$2.52B
| $649K | 0.06% |
+9,373
| New | +$882K |
|
|
BHVN
387
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $647K | 0.06% |
19,004
-16,810
| -47% | -$769K |
|
388
Atara Biotherapeutics
ATRA
$97.4M
| $646K | 0.06% |
3,039
+1,269
| +72% | +$403K |
|
|
EQC
389
DELISTED
Equity Commonwealth
EQC
| $646K | 0.06% |
+20,357
| New | +$652K |
|
390
Orthofix Medical
OFIX
$408M
| $637K | 0.06% |
22,754
+7,399
| +48% | +$286K |
|
|
SPTN
391
DELISTED
SpartanNash
SPTN
| $637K | 0.06% |
44,509
+9,729
| +28% | +$125K |
|
392
Benchmark Electronics
BHE
$2.61B
| $634K | 0.06% |
+31,692
| New | +$897K |
|
393
Palo Alto Networks
PANW
$292B
| $634K | 0.06% |
23,196
-65,142
| -74% | -$2.27M |
|
394
Tapestry
TPR
$26B
| $634K | 0.06% |
48,947
+6,225
| +15% | +$146K |
|
395
Capital One
COF
$134B
| $632K | 0.06% |
+12,531
| New | +$1.1M |
|
396
Darling Ingredients
DAR
$10.4B
| $632K | 0.06% |
+32,961
| New | +$836K |
|
|
SEE
397
DELISTED
Sealed Air
SEE
| $632K | 0.06% |
25,560
+8,151
| +47% | +$266K |
|
398
Travel + Leisure Co
TNL
$4.39B
| $632K | 0.06% |
+29,147
| New | +$1.21M |
|
399
Moody's
MCO
$87.2B
| $631K | 0.06% |
2,982
+1,528
| +105% | +$371K |
|
400
Medtronic
MDT
$119B
| $627K | 0.06% |
6,956
-6,274
| -47% | -$667K |
|
Similar funds
Paul Tudor Jones's Q1 2020 Portfolio in Review
As of Q1 2020, Paul Tudor Jones held 1,500 positions worth $1.12B, down 50% from $2.23B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Paul Tudor Jones withdrew a net $741M in Q1 2020, closing 486 positions and reducing 367 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $27M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, Paul Tudor Jones opened a new position in GCI Liberty, Inc. Class A Common Stock (DE) worth $7.42M.
- Paul Tudor Jones's largest Q1 2020 buy was GCI Liberty, Inc. Class A Common Stock (DE): 130,150 shares worth $7.42M.
- Paul Tudor Jones added most to RTX Corp in Q1 2020, an estimated $34.4M increase.
- Paul Tudor Jones's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $44.5M.
- Paul Tudor Jones fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $27M.
- Paul Tudor Jones's ten largest holdings make up 28% of its $1.12B portfolio in Q1 2020.
- Paul Tudor Jones opened 388 new positions and closed 486 in Q1 2020.
- Paul Tudor Jones's portfolio value fell 50% quarter-over-quarter to $1.12B.
Based on Tudor Investment Corp's 13F filing for Q1 2020, filed 15 May 2020.